Biofrontera Inc.

NASDAQ (USD): Biofrontera Inc. (BFRI)

Last Price

1.42

Today's Change

+0.486 (52.03%)

Day's Change

0.795 - 2.21

Trading Volume

125,351,347

Overview

Market Cap

7 Million

Shares Outstanding

5 Million

Avg Volume

410,387

Avg Price (50 Days)

1.07

Avg Price (200 Days)

1.20

PE Ratio

-0.53

EPS

-2.74

Earnings Announcement

09-Nov-2024

Previous Close

0.93

Open

0.84

Day's Range

0.7946 - 2.2101

Year Range

0.61 - 5.225

Trading Volume

125,536,240

Price Change Highlight

1 Day Change

54.44%

5 Day Change

53.58%

1 Month Change

8.65%

3 Month Change

20.42%

6 Month Change

-21.47%

Ytd Change

-48.39%

1 Year Change

-69.26%

3 Year Change

-98.25%

5 Year Change

-98.36%

10 Year Change

-98.36%

Max Change

-98.36%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment